Gefitinib inhibits the growth and invasion of urothelial carcinoma cell lines in which Akt and MAPK activation is dependent on constitutive epidermal growth factor receptor activation.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples